Here, we used a previously described cohort 26 that we classified into two groups: patients with poorly differentiated HCC and low macroH2A1 expression; and patients with well-differentiated HCC and high macroH2A1 expression (Figure 7). Here, MACROH2A1 is linked to hepatocellular carcinoma.